The New York Times reports on concerns in the biomedical community about what to do as our ability to detect tumors improves -- to the point where even the slightest number of cancerous cells will send up the alarm. As genomic tests advance, sensitivity will only increase -- but what does that mean for patients who may be treated for cancer when really they're quite healthy? From the article: